Approval · Notice of Compliance 15525 · 2014
RAMIPRIL: Notice of Compliance 15525
Issued April 23, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15525
- Date
- April 23, 2014
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- Angiotensin converting enzyme inhibitor
- Canadian reference product
- ALTACE (Hoechst Marion Roussel Canada Inc.)